Search results for "dietetics"

showing 10 items of 2146 documents

Nutrient sensing: What can we learn from different tastes about the nutrient contents in today's foods?

2019

Abstract Tastes are often described as having a nutrient-signaling function eliciting expectations about the food and its nutrient content. The objectives of this work was to investigate correlations between taste intensity and nutrient content, to evaluate the impact of competing tastes on these relationships, and to know if the content in certain nutrients could be inferred from a combination of tastes. The Food Taste Database (Martin et al., 2014) and a French Food Composition table (ANSES-Ciqual) were used to obtain a dataset combining sensory and nutritional information for 365 foods. Our results confirm the existence of several taste-nutrient relationships previously suggested by othe…

nutrient sensingTaste030309 nutrition & dieteticsUmamiNutrient sensing03 medical and health sciences0404 agricultural biotechnologyNutrientFood sciencefood taste data baseMathematics0303 health sciencesnutrient contentNutrition and Dieteticsbusiness.industryFood composition dataSweet taste04 agricultural and veterinary sciences040401 food sciencetaste intensityTaste intensityFood processingrelationshipbusiness[SDV.AEN]Life Sciences [q-bio]/Food and NutritionFood Science
researchProduct

Diet to Reduce the Metabolic Syndrome Associated with Menopause. The Logic for Olive Oil

2020

The rates of metabolic syndrome are increasing in parallel with the increasing prevalence of obesity, primarily due to its concomitant insulin resistance. This is particularly concerning for women, as the years around menopause are accompanied by an increase in visceral obesity, a strong determinant of insulin resistance. A fall in estrogens and increase in the androgen/estrogen ratio is attributed a determining role in this process, which has been confirmed in other physiological models, such as polycystic ovary syndrome. A healthy lifestyle, with special emphasis on nutrition, has been recommended as a first-line strategy in consensuses and guidelines. A consistent body of evidence has ac…

obesityMediterranean dietmedicine.drug_classmenopausePhysiologylcsh:TX341-641030209 endocrinology & metabolismReviewDisease030204 cardiovascular system & hematologyDiet Mediterraneanmetabolic syndromeHealthy Aging03 medical and health sciences0302 clinical medicineInsulin resistanceHumansMedicineNutritional Physiological PhenomenaHealthy LifestyleAgedNutrition and Dieteticsbusiness.industryEstrogensMiddle Agedolive oilmedicine.diseasePolycystic ovaryObesityMenopauseEstrogenObesity AbdominalAndrogensFemalewomenDiet HealthyInsulin ResistanceMetabolic syndromehealthy ageingbusinesslcsh:Nutrition. Foods and food supplyFood ScienceNutrients
researchProduct

Impact of Obesity in Kidney Diseases.

2021

The clinical consequences of obesity on the kidneys, with or without metabolic abnormalities, involve both renal function and structures. The mechanisms linking obesity and renal damage are well understood, including several effector mechanisms with interconnected pathways. Higher prevalence of urinary albumin excretion, sub-nephrotic syndrome, nephrolithiasis, increased risk of developing CKD, and progression to ESKD have been identified as being associated with obesity and having a relevant clinical impact. Moreover, renal replacement therapy and kidney transplantation are also influenced by obesity. Losing weight is key in limiting the impact that obesity produces on the kidneys by reduc…

obesityNutrition and DieteticsNutrition. Foods and food supplybariatric surgeryfatty kidneyReviewurologic and male genital diseasesKidney TransplantationglomerulopathyRisk FactorsCKDHumansTX341-641Kidney DiseasesESRDDialysisFood ScienceNutrients
researchProduct

Taste of Fat and Obesity: Different Hypotheses and Our Point of View

2022

Obesity results from a temporary or prolonged positive energy balance due to an alteration in the homeostatic feedback of energy balance. Food, with its discriminative and hedonic qualities, is a key element of reward-based energy intake. An alteration in the brain reward system for highly palatable energy-rich foods, comprised of fat and carbohydrates, could be one of the main factors involved in the development of obesity by increasing the attractiveness and consumption of fat-rich foods. This would induce, in turn, a decrease in the taste of fat. A better understanding of the altered reward system in obesity may open the door to a new era for the diagnosis, management and treatment of th…

obesityNutrition and Dieteticsfood intakeRewardreward systemNutrition. Foods and food supplyTasteHomeostasisHumansTX341-641Energy MetabolismFood Sciencefat tasteNutrients
researchProduct

Innovations in Infant Feeding: Future Challenges and Opportunities in Obesity and Cardiometabolic Disease

2020

The field of nutrition in early life, as an effective tool to prevent and treat chronic diseases, has attracted a large amount of interest over recent years. The vital roles of food products and nutrients on the body’s molecular mechanisms have been demonstrated. The knowledge of the mechanisms and the possibility of controlling them via what we eat has opened up the field of precision nutrition, which aims to set dietary strategies in order to improve health with the greatest effectiveness. However, this objective is achieved only if the genetic profile of individuals and their living conditions are also considered. The relevance of this topic is strengthened considering the importance of …

obesityPediatric ObesityInfants AlimentacióRevieweating behaviorGenetic profile0302 clinical medicineNutrigenomicsPregnancy030212 general & internal medicinePrecision MedicineChildprecision nutritionPediatriaNutrition and DieteticsNutrigenomicsCardiovascular DiseasesChild PreschoolObesitatFemaleDiet HealthyChild Nutritional Physiological Phenomenalcsh:Nutrition. Foods and food supplypediatricsAdolescentNutritional Statuslcsh:TX341-641030209 endocrinology & metabolismChildhood obesityNutrigenetics03 medical and health sciencesEnvironmental healthmedicinemicrobiotaHumansMetabolomicsGenetic Predisposition to DiseaseInfant feedingnutrigeneticsbusiness.industryInfant NewbornInfantFeeding Behaviormedicine.diseaseCardiometabolic diseaseObesitycardiometabolic risk factorsGastrointestinal MicrobiomeFood productsAvaluació del riscbusinessFood ScienceNutrients
researchProduct

Impact of intermittent energy restriction on anthropometric outcomes and intermediate disease markers in patients with overweight and obesity: system…

2020

This systematic review aims to investigate the effects of intermittent energy restriction (IER) on anthropometric outcomes and intermediate disease markers. A systematic literature search was conducted in three electronic databases. Randomized controlled trials (RCTs) were included if the intervention lasted ≥12 weeks and IER was compared with either continuous energy restriction (CER) or a usual diet. Random-effects meta-analysis was performed for eight outcomes. Certainty of evidence was assessed using GRADE. Seventeen RCTs with 1328 participants were included. IER in comparison to a usual diet may reduce body weight (mean difference [MD]: −4.83 kg, 95%-CI: −5.46, −4.21; n = 6 RCTs), wais…

obesityPediatricsmedicine.medical_specialty030309 nutrition & dieteticsOverweightalternateday fastingIndustrial and Manufacturing Engineering03 medical and health sciences0404 agricultural biotechnologyWeight lossIntermittent fastingHumanscontinuous energy restrictionMedicineMeta-analysialternate-day fasting; continuous energy restriction; intermittent energy restriction; Meta-analysis; obesity; weight lossIn patientDisease markers0303 health sciencesbusiness.industryBody Weight04 agricultural and veterinary sciencesGeneral MedicineOverweightAnthropometrymedicine.disease040401 food scienceObesityMeta-analysisMeta-analysisweight lossmedicine.symptomEnergy Intakebusinessalternate-day fastingintermittent energy restrictionFood ScienceCritical Reviews in Food Science and Nutrition
researchProduct

COVID Obesity: A One-Year Narrative Review

2021

On 11 March 2020, coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization (WHO). This study focuses on a narrative review about the illness during the first year of the pandemic in relation to obesity. Databases were used to search studies published up to 8 December 2020. In total, 4430 articles and other scientific literature were found, and 24 articles were included in this one-year narrative review. The mean BMI value of severe COVID-19 patients ranged from 24.5 to 33.4 kg/m2, versus 2 for non-severe patients. Articles using the terms obesity or overweight without indicating the BMI value in these patients were common, but this is not useful, as the a…

obesityReviewComorbidityScientific literature030204 cardiovascular system & hematologyOverweightSeverity of Illness IndexCOVID obesityBody Mass IndexBMI03 medical and health sciences0302 clinical medicinePandemicSeverity of illnessHumansoverweightMedicineTX341-641030212 general & internal medicineEpidemiologiaPandemicsNutrition and DieteticsSARS-CoV-2Nutrition. Foods and food supplybusiness.industryCOVID-19Anthropometrymedicine.diseaseObesityComorbiditynutritionTrastorns de la nutricióObesitatmedicine.symptombusinessBody mass indexFood ScienceDemographyNutrients
researchProduct

The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms.

2015

Objectives:\ud The corticotrophin-releasing factor (CRF)/urocortin system is expressed in the adipose tissue of mammals, but its functional role in this tissue remains unknown.\ud \ud Methods:\ud Pharmacological manipulation of the activity of CRF receptors, CRF1 and CRF2, was performed in 3T3L1 white pre-adipocytes and T37i brown pre-adipocytes during in vitro differentiation. The expression of genes of the CRF/urocortin system and of markers of white and brown adipocytes was evaluated along with mitochondrial biogenesis and cellular oxygen consumption. Metabolic evaluation of corticosterone-deficient or supplemented Crhr1-null (Crhr1−/−) mice and their wild-type controls was performed alo…

obesitycrf1Corticotropin-Releasing Hormonecrf2Endocrinology Diabetes and MetabolismIMPAIRED STRESS-RESPONSE[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionAdipocytes WhiteMedicine (miscellaneous)urocortinWhite adipose tissueMOUSEMicebrown adiposte tissue0302 clinical medicineBrowningUrocortinsUrocortin0303 health sciencesNutrition and Dietetics[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismParacrine mechanisms[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismImmunohistochemistryADIPOCYTESAdipocytes BrownADIPOSE-TISSUESKELETAL-MUSCLEhormones hormone substitutes and hormone antagonistsSignal TransductionEXPRESSIONmedicine.medical_specialtyendocrine systemTHERMOGENESISBiologycrfReceptors Corticotropin-Releasing Hormone03 medical and health scienceswhite adipose tissueInternal medicine3T3-L1 CellsmedicineAnimalsRNA MessengerGLUCOCORTICOIDS030304 developmental biologyENERGY HOMEOSTASISCorticotrophin releasing factoradipose plasticityPigments BiologicalUROCORTIN-II GENEQPEndocrinologyGene Expression Regulation[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition030217 neurology & neurosurgery
researchProduct

Intermittent Fasting and the Possible Benefits in Obesity, Diabetes, and Multiple Sclerosis: A Systematic Review of Randomized Clinical Trials

2021

Intermittent fasting has become popular in recent years and is controversially presented as a possible therapeutic adjunct. A bibliographic review of the literature on intermittent fasting and obesity, diabetes, and multiple sclerosis was carried out. The scientific quality of the methodology and the results obtained were evaluated in pairs. Intermittent fasting has beneficial effects on the lipid profile, and it is associated with weight loss and a modification of the distribution of abdominal fat in people with obesity and type 2 diabetes as well as an improvement in the control of glycemic levels. In patients with multiple sclerosis, the data available are too scarce to draw any firm con…

obesitymedicine.medical_specialtyMultiple SclerosisGlycemic ControlReviewType 2 diabeteslaw.inventionRandomized controlled trialWeight losslawDiabetes mellitusIntermittent fastingHumansMedicineTX341-641Intensive care medicineRandomized Controlled Trials as TopicGlycemicNutrition and Dieteticsexercisemedicine.diagnostic_testNutrition. Foods and food supplyintermittent fastingbusiness.industryFastingmedicine.diseaseObesityDiabetes Mellitus Type 2type 2 diabetesmedicine.symptombusinessLipid profileFood ScienceNutrients
researchProduct

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches

2013

Small, dense low density lipoprotein (sdLDL) represents an emerging cardiovascular risk factor, since these particles can be associated with cardiovascular disease (CVD) independently of established risk factors, including plasma lipids. Obese subjects frequently have atherogenic dyslipidaemia, including elevated sdLDL levels, in addition to elevated triglycerides (TG), very low density lipoprotein (VLDL) and apolipoprotein-B, as well as decreased high density lipoprotein cholesterol (HDL-C) levels. Obesity-related co-morbidities, such as metabolic syndrome (MetS) are also characterized by dyslipidaemia. Therefore, agents that favourably modulate LDL subclasses may be of clinical value in t…

obesitymedicine.medical_specialtyVery low-density lipoproteinLipoproteinslipid-lowering drugsanti-obesity drugslcsh:TX341-641030209 endocrinology & metabolismReview030204 cardiovascular system & hematologyOverweight03 medical and health scienceschemistry.chemical_compound0302 clinical medicineHigh-density lipoproteinInternal medicineHumansMedicineRisk factorDyslipidemiasMetabolic Syndromeobesity treatmentNutrition and Dieteticssmall dense low density lipoproteinbusiness.industryCholesterollipoproteinmedicine.disease3. Good healthEndocrinologychemistryCardiovascular DiseasesLow-density lipoproteinlipids (amino acids peptides and proteins)Metabolic syndromemedicine.symptombusinesslcsh:Nutrition. Foods and food supplyanti-obesity drugFood ScienceLipoproteinNutrients
researchProduct